Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deepali Gupta

Showing results (121-130 of 130) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 130 results.
The Journal of Clinical Investigation|December 15, 2023
Ghrelin deletion and conditional ghrelin cell ablation increase pancreatic islet size in miceDeepali Gupta, Avi W Burstein, Dana C Schwalbe, et al.
Cell Reports|September 4, 2025
Temporal control of eating and body weight by GHSR-expressing suprachiasmatic nucleus neuronsOmprakash Singh, Sepideh Sheybani-Deloui, Soumya Kulkarni, et al.
Internal Medicine Journal|December 12, 2022
Secular trends in the utility of SGLT-2 inhibitors in heart failure patients with type 2 diabetes mellitus across Metro South Health hospitals in South-East QueenslandZhen Qi Lu, Elizabeth McCourt, Karen Goodhew, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 23, 2025
Safety and Efficacy of Pemivibart, a Long-Acting Monoclonal Antibody, for Prevention of Symptomatic COVID-19: Interim Results From a Phase 3 Randomized Clinical Trial (CANOPY)Cameron R Wolfe, Jonathan Cohen, Kathryn Mahoney, et al.
Endocrinology|July 3, 2026
Loss of the calorie restriction response protein DEPP1 worsens diet-induced obesitySepideh Sheybani-Deloui, Kripa Shankar, Angie L Bookout, et al.
Endocrinology|November 1, 2018
Ghrelin Receptor Agonist Rescues Excess Neonatal Mortality in a Prader-Willi Syndrome Mouse ModelJuan A Rodriguez, Emily C Bruggeman, Bharath K Mani, et al.
Open Forum Infectious Diseases|June 23, 2023
Efficacy and Safety of Adintrevimab (ADG20) for the Treatment of High-Risk Ambulatory Patients With Mild or Moderate Coronavirus Disease 2019: Results From a Phase 2/3, Randomized, Placebo-Controlled Trial (STAMP) Conducted During Delta Predominance and Early Emergence of OmicronMichael G Ison, Myra Popejoy, Nikolay Evgeniev, et al.
Molecular Metabolism|May 2, 2024
A long-acting LEAP2 analog reduces hepatic steatosis and inflammation and causes marked weight loss in miceKripa Shankar, Nathan P Metzger, Connor Lawrence, et al.
Endocrinology|September 27, 2024
The LEAP2 Response to Cancer-Related Anorexia-Cachexia Syndrome in Male Mice and PatientsSalil Varshney, Kripa Shankar, Haiming L Kerr, et al.
Journal of Neurochemistry|July 19, 2019
The energetic brain - A review from students to studentsMelina Paula Bordone, Mootaz M Salman, Haley E Titus, et al.
Pageof 13

Showing results (121-130 of 130) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 130 results.
The Journal of Clinical Investigation|December 15, 2023
Ghrelin deletion and conditional ghrelin cell ablation increase pancreatic islet size in miceDeepali Gupta, Avi W Burstein, Dana C Schwalbe, et al.
Cell Reports|September 4, 2025
Temporal control of eating and body weight by GHSR-expressing suprachiasmatic nucleus neuronsOmprakash Singh, Sepideh Sheybani-Deloui, Soumya Kulkarni, et al.
Internal Medicine Journal|December 12, 2022
Secular trends in the utility of SGLT-2 inhibitors in heart failure patients with type 2 diabetes mellitus across Metro South Health hospitals in South-East QueenslandZhen Qi Lu, Elizabeth McCourt, Karen Goodhew, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 23, 2025
Safety and Efficacy of Pemivibart, a Long-Acting Monoclonal Antibody, for Prevention of Symptomatic COVID-19: Interim Results From a Phase 3 Randomized Clinical Trial (CANOPY)Cameron R Wolfe, Jonathan Cohen, Kathryn Mahoney, et al.
Endocrinology|July 3, 2026
Loss of the calorie restriction response protein DEPP1 worsens diet-induced obesitySepideh Sheybani-Deloui, Kripa Shankar, Angie L Bookout, et al.
Endocrinology|November 1, 2018
Ghrelin Receptor Agonist Rescues Excess Neonatal Mortality in a Prader-Willi Syndrome Mouse ModelJuan A Rodriguez, Emily C Bruggeman, Bharath K Mani, et al.
Open Forum Infectious Diseases|June 23, 2023
Efficacy and Safety of Adintrevimab (ADG20) for the Treatment of High-Risk Ambulatory Patients With Mild or Moderate Coronavirus Disease 2019: Results From a Phase 2/3, Randomized, Placebo-Controlled Trial (STAMP) Conducted During Delta Predominance and Early Emergence of OmicronMichael G Ison, Myra Popejoy, Nikolay Evgeniev, et al.
Molecular Metabolism|May 2, 2024
A long-acting LEAP2 analog reduces hepatic steatosis and inflammation and causes marked weight loss in miceKripa Shankar, Nathan P Metzger, Connor Lawrence, et al.
Endocrinology|September 27, 2024
The LEAP2 Response to Cancer-Related Anorexia-Cachexia Syndrome in Male Mice and PatientsSalil Varshney, Kripa Shankar, Haiming L Kerr, et al.
Journal of Neurochemistry|July 19, 2019
The energetic brain - A review from students to studentsMelina Paula Bordone, Mootaz M Salman, Haley E Titus, et al.
Pageof 13